KMWM
REGN icon

Keudell/Morrison Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Keudell/Morrison Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Buy
582
+15
+3% +$10.2K 0.07% 173
2026
Q1 		$438K Sell
567
-27
-5% -$20.7K 0.09% 142
2025
Q4 		$459K Buy
+594
New +$403K 0.1% 139
2025
Q2 		$365K Buy
695
+110
+19% +$61.4K 0.08% 151
2025
Q1 		$371K Buy
585
+36
+7% +$24.8K 0.09% 139
2024
Q4 		$391K Buy
549
+165
+43% +$138K 0.1% 134
2024
Q3 		$404K Hold
384
– – 0.11% 128
2024
Q2 		$404K Hold
384
– – 0.12% 134
2024
Q1 		$370K Hold
384
– – 0.11% 139
2023
Q4 		$337K Hold
384
– – 0.11% 142
2023
Q3 		$316K Hold
384
– – 0.1% 139
2023
Q2 		$276K Hold
384
– – 0.08% 155
2023
Q1 		$316K Hold
384
– – 0.09% 139
2022
Q4 		$277K Hold
384
– – 0.09% 147
2022
Q3 		$265K Sell
384
-30
-7% -$18.9K 0.1% 146
2022
Q2 		$245K Sell
414
-52
-11% -$33.8K 0.09% 152
2022
Q1 		$325K Sell
466
-6
-1% -$3.8K 0.14% 137
2021
Q4 		$298K Sell
472
-115
-20% -$70.7K 0.12% 140
2021
Q3 		$355K Sell
587
-39
-6% -$24.2K 0.15% 121
2021
Q2 		$350K Hold
626
– – 0.19% 123
2021
Q1 		$296K Sell
626
-438
-41% -$213K 0.17% 130
2020
Q4 		$514K Sell
1,064
-5
-0.5% -$2.7K 0.33% 88
2020
Q3 		$598K Sell
1,069
-23
-2% -$13.9K 0.38% 72
2020
Q2 		$681K Hold
1,092
– – 0.56% 64
2020
Q1 		$533K Buy
1,092
+60
+6% +$24.7K 0.52% 68
2019
Q4 		$387K Sell
1,032
-202
-16% -$68K 0.27% 96
2019
Q3 		$342K Buy
1,234
+30
+2% +$8.88K 0.28% 99
2019
Q2 		$364K Sell
1,204
-12
-1% -$4K 0.32% 88
2019
Q1 		$499K Buy
+1,216
New +$501K 0.44% 77

Other funds holding REGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Keudell/Morrison Wealth Management's REGN Position: Q2 2026 in Review

Keudell/Morrison Wealth Management increased its Regeneron Pharmaceuticals (REGN) stake by 2.6% in Q2 2026, buying an estimated $10.2K and bringing the position to 582 shares worth $363K. The position accounts for 0.07% of the portfolio, ranked #173.

Keudell/Morrison Wealth Management first reported a position in REGN in Q1 2019 and has held it in 29 quarters since. The position peaked at $681K in Q2 2020. 180 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Keudell/Morrison Wealth Management held 582 shares of Regeneron Pharmaceuticals worth $363K as of Q2 2026.
  • Keudell/Morrison Wealth Management bought 15 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $10.2K.
  • Regeneron Pharmaceuticals made up 0.07% of Keudell/Morrison Wealth Management's portfolio in Q2 2026, its #173 holding.
  • Keudell/Morrison Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 29 quarters since.
  • Keudell/Morrison Wealth Management's Regeneron Pharmaceuticals position peaked at $681K in Q2 2020.
  • 180 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Keudell/Morrison Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.